Clinical trial
Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer
NCT00004924
Study timeline
Study start (unknown)1999-03-01Date precision: month
Registry last updated2009-08-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancerunresolved
Interventions
irinotecan hydrochlorideDRUG · verified · RxNorm: irinotecan hydrochloride
paclitaxelDRUG · verified · RxNorm: paclitaxel
Sponsors & collaborators
Yale Universitylead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00004924 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.